The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFOBenzinga via Yahoo FinanceAug 27 11:29 AM
Health Inc (NYSE: ELAN)(Bank of America downgraded the shares to Neutral) Neurometrix Inc (NASDAQ: NURO) Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Stealth BioTherapeutics ...
Anti-epileptic Drugs for Pediatrics Market Insights, Forecast to 2018 Analysis by Application, Size, Production, Market Share, Consumption, Trends and...Market Watch2 days ago
Inflammatory Bowel Disease Treatment Market 2018 Global Overview, Latest Technologies, Business Strategy, Key Vendors, Segments, Demands...Market Watch6 days ago
Circulating Tumor Cell (CTC) Diagnostics Market Size, Application Analysis, Outlook, Competitive Strategies And Forecast 2024Market Watch2 days ago
- Benzinga via Yahoo FinanceAug 28 12:02 PM
PDUFA dates are deadlines for the FDA to review new drugs. The FDA is normally given 10 months to review new drugs. If a drug is selected for priority review, the FDA is allotted six months to review the drug.
- Thomson Reuters StreetEvents via Yahoo FinanceSep 06 14:33 PM
Please be advised that this call is being recorded at the company's request, and it will be archived on Cumberland's website for 1 more -- for 1 week for today's -- from today's update. Now ...
- Zacks via Yahoo FinanceSep 10 15:46 PM
Theravance Biopharma, Inc. TBPH announced promising outcomes in the areas of safety and tolerability, pharmacokinetics and preliminary pharmacodynamic activity from a phase I study on ...